About Hytanbio Tech: Founded in Hong Kong in 2026 for overseas business development, Hytanbio Tech works with an in-house commercial manufacturing base founded in 2014 in Shaoxing, Mainland China. The platform supports peptide raw materials, lyophilized formats, cosmetic delivery systems and OEM/ODM projects.
Research and manufacturing platform
The company reports an R&D center covering more than 4,000 square meters, multiple peptide production lines, large-scale peptide synthesizers, analytical and preparative HPLC systems, and GMP-standard clean laboratory areas. These capabilities support feasibility review, pilot sampling, specification confirmation and commercial production planning. Equipment and capacity vary by route; buyers should request a project-specific capability statement before relying on any production scale, purity target or timeline in a purchase decision. The Shaoxing facility and Hong Kong business entity play distinct roles in the supply chain.
Quality and commercial handoff
The company states that its quality management system complies with ISO 9001:2015 certification. Buyers should review the actual certificate, covered legal entity, location, activity and validity period during supplier qualification. Batch-wise quality documentation, traceability, export coordination and destination-market requirements are discussed during the quotation process. The portfolio spans peptide raw materials, lyophilized peptide powder, dissolvable microneedle patches, dissolvable oral films and private-label development. Contact the team for a scoped technical conversation rather than treating a public listing as a signed specification.